QUANTRO Therapeutics Secures Austrian Research Grant To Expand AI-Powered Drug Discovery Platform
· pulse2.com · popularity 20/100 · 0 similar stories today · Genetics, Genomics & Biotech (Science)
Read the original at pulse2.com →
Summary
QUANTRO Therapeutics, a Vienna-based biotechnology company developing medicines targeting transcription factors, has secured a 12-month non-dilutive research grant from the Austrian Research Promotion Agency (FFG) to accelerate development of its AI-powered medicinal chemistry platform, ASCEND. The post QUANTRO Therapeutics Secures Austrian Research Grant To Expand AI-Powered Drug Discovery Platform appeared first on Pulse 2.0 .
Found in: Pulse 2.0. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 4.